• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

月经周期生物标志物在多囊卵巢综合征不孕症治疗中的成功应用——病例报告

Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome-Case Report.

作者信息

Kicińska Aleksandra M, Stachowska Aneta, Kajdy Anna, Wierzba Tomasz H, Maksym Radosław B

机构信息

Department of Physiology, Faculty of Medicine, Medical University of Gdańsk, ul. Debinki 1, 80-210 Gdańsk, Poland.

1st Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, ul. Żelazna 90, 02-004 Warszawa, Poland.

出版信息

Healthcare (Basel). 2023 Feb 18;11(4):616. doi: 10.3390/healthcare11040616.

DOI:10.3390/healthcare11040616
PMID:36833150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9956032/
Abstract

Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Absent, impaired, or rare ovulation induces progesterone deficiency in the luteal phase, which is a critical problem in PCOS. A usual pattern of progesterone administration from a fixed and arbitrary pre-determined day of a menstrual cycle may preserve infertility but can easily be avoided. We present the case of a 29-year-old infertile woman who had been ineffectively treated for over two years. We introduced a line of therapy that was suited to her individual menstrual cycle by implementing biomarker recording. Supplementation based on a standardized observation of the basal body temperature (BBT) and cervical mucus stopped the vicious circle of absent ovulation and hyperandrogenism, restoring regular bleeding, ovulation cycles, and fertility. The implementation of a reliable fertility awareness method (FAM), accompanied by a standardized teaching methodology and periodic review of the observations recorded by the patient, validated through an ultrasound examination and plasma gonadotropins, estrogens, and progesterone concentrations, is key to achieving therapeutic success. The presented case is an example of a clinical vignette for many patients who have successfully managed to improve their fertility and pregnancy outcomes by applying the principles of a personalized treatment approach together with gestagens by recording their fertility biomarkers.

摘要

多囊卵巢综合征(PCOS)是无排卵性不孕症最常见的病因。黄体期无排卵、排卵功能受损或排卵稀少会导致孕酮缺乏,这是PCOS中的一个关键问题。在月经周期中从固定且随意预先确定的日期开始进行常规的孕酮给药模式可能会持续导致不孕,但这很容易避免。我们介绍了一位29岁不孕女性的病例,她接受了两年多的无效治疗。我们通过实施生物标志物记录引入了一种适合她个人月经周期的治疗方法。基于对基础体温(BBT)和宫颈黏液的标准化观察进行补充治疗,打破了无排卵和高雄激素血症的恶性循环,恢复了规律出血、排卵周期和生育能力。实施可靠的生育力意识方法(FAM),并辅以标准化的教学方法以及对患者记录的观察结果进行定期复查,通过超声检查以及血浆促性腺激素、雌激素和孕酮浓度进行验证,是取得治疗成功的关键。本病例是一个临床案例,许多患者通过记录其生育生物标志物,应用个性化治疗方法的原则并联合使用孕激素,成功改善了生育能力和妊娠结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/9db7ebb60d47/healthcare-11-00616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/4516b054cf7e/healthcare-11-00616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/286bb4c33514/healthcare-11-00616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/9db7ebb60d47/healthcare-11-00616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/4516b054cf7e/healthcare-11-00616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/286bb4c33514/healthcare-11-00616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec4c/9956032/9db7ebb60d47/healthcare-11-00616-g003.jpg

相似文献

1
Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome-Case Report.月经周期生物标志物在多囊卵巢综合征不孕症治疗中的成功应用——病例报告
Healthcare (Basel). 2023 Feb 18;11(4):616. doi: 10.3390/healthcare11040616.
2
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.多囊卵巢综合征患者排卵障碍性不孕的管理:支持制定全球世卫组织指南的证据分析。
Hum Reprod Update. 2016 Nov;22(6):687-708. doi: 10.1093/humupd/dmw025. Epub 2016 Aug 10.
3
Usefulness of the Sympto-Thermal Method with Standardized Cervical Mucus Assessment (InVivo Method) for Evaluating the Monthly Cycle in Women with Polycystic Ovary Syndrome (PCOS).采用标准化宫颈黏液评估的症状体温法(体内法)评估多囊卵巢综合征(PCOS)女性月经周期的效用。
Healthcare (Basel). 2024 May 29;12(11):1108. doi: 10.3390/healthcare12111108.
4
[The "regulating conception-governor vessel" acupuncture method for infertility of polycystic ovarian syndrome].[“调神针法”治疗多囊卵巢综合征所致不孕症]
Zhongguo Zhen Jiu. 2016 Dec 12;36(12):1237-1241. doi: 10.13703/j.0255-2930.2016.12.002.
5
Characteristics of menstrual cycles with or without intercourse in women with no known subfertility.无已知生育力低下的女性有或无性交情况下月经周期的特征
Hum Reprod Open. 2022 Sep 27;2022(4):hoac039. doi: 10.1093/hropen/hoac039. eCollection 2022.
6
Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.使用卵巢监测仪通过测量尿排泄率监测卵巢活动,第四部分:孕二醇葡萄糖醛酸苷阈值与基础体温及宫颈黏液的关系,作为排卵后不孕期开始的标志
Hum Reprod. 2016 Feb;31(2):445-53. doi: 10.1093/humrep/dev303. Epub 2015 Dec 17.
7
Pulsatility and Resistance Indices of Uterine and Ovarian Arteries in Anovulatory Women With Polycystic Ovary Syndrome.多囊卵巢综合征排卵障碍妇女的子宫和卵巢动脉搏动指数和阻力指数。
Ultrasound Q. 2021 Sep 1;37(3):248-253. doi: 10.1097/RUQ.0000000000000579.
8
Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.奥那司酮(ZK 98.299):一种用于子宫内膜避孕的潜在抗孕激素。
Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):779-87. doi: 10.1016/0002-9378(95)90341-0.
9
Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature.使用一种基于网络的新型医疗设备,通过阴道生物传感器测量昼夜节律和月经周期核心体温,来识别和预测生育窗口。
Gynecol Endocrinol. 2018 Mar;34(3):256-260. doi: 10.1080/09513590.2017.1390737. Epub 2017 Oct 28.
10
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.一线诱导排卵治疗多囊卵巢综合征:一项个体参与者数据荟萃分析。
Hum Reprod Update. 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029.

引用本文的文献

1
Usefulness of the Sympto-Thermal Method with Standardized Cervical Mucus Assessment (InVivo Method) for Evaluating the Monthly Cycle in Women with Polycystic Ovary Syndrome (PCOS).采用标准化宫颈黏液评估的症状体温法(体内法)评估多囊卵巢综合征(PCOS)女性月经周期的效用。
Healthcare (Basel). 2024 May 29;12(11):1108. doi: 10.3390/healthcare12111108.
2
Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy.多囊卵巢综合征中的着床和蜕膜化:揭示妊娠的复杂性。
Int J Mol Sci. 2024 Jan 18;25(2):1203. doi: 10.3390/ijms25021203.
3
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome.

本文引用的文献

1
Evaluation of causes of female infertility using ultrasonography in Najran, Saudi Arabia.沙特阿拉伯纳季兰地区应用超声技术评估女性不孕原因。
Afr J Reprod Health. 2022 May;26(5):90-95. doi: 10.29063/ajrh2022/v26i5.10.
2
Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations.多囊卵巢综合征:聚焦种族和地理差异影响的最新综述
Life (Basel). 2022 Nov 25;12(12):1974. doi: 10.3390/life12121974.
3
Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception?多囊卵巢综合征(PCOS):挑战是否在受孕时结束?
多囊卵巢综合征不孕症的免疫和代谢原因
Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567.
Int J Environ Res Public Health. 2022 Nov 12;19(22):14914. doi: 10.3390/ijerph192214914.
4
Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea.适应性、可逆性下丘脑性生殖抑制:不止是功能性下丘脑性闭经。
Front Endocrinol (Lausanne). 2022 Oct 19;13:893889. doi: 10.3389/fendo.2022.893889. eCollection 2022.
5
Fertility Awareness-Based Methods for Women's Health and Family Planning.基于生育意识的女性健康与计划生育方法。
Front Med (Lausanne). 2022 May 24;9:858977. doi: 10.3389/fmed.2022.858977. eCollection 2022.
6
Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019.多囊卵巢综合征在 204 个国家和地区的流行率、发病率和残疾生存年数,1990-2019 年。
Hum Reprod. 2022 Jul 30;37(8):1919-1931. doi: 10.1093/humrep/deac091.
7
Immune regulation in polycystic ovary syndrome.多囊卵巢综合征的免疫调节。
Clin Chim Acta. 2022 Jun 1;531:265-272. doi: 10.1016/j.cca.2022.04.234. Epub 2022 Apr 18.
8
Progesterone and Inflammatory Response in the Oviduct during Physiological and Pathological Conditions.孕激素在生理和病理条件下对输卵管炎症反应的影响。
Cells. 2022 Mar 23;11(7):1075. doi: 10.3390/cells11071075.
9
Do fertility tracking applications offer women useful information about their fertile window?生育追踪应用程序能为女性提供有关其易孕期的有用信息吗?
Reprod Biomed Online. 2020 Sep 11. doi: 10.1016/j.rbmo.2020.09.005.
10
Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)-A 6-Month Pilot Study of a Single Woman's Experience Changes.《雄激素性多囊卵巢综合征(PCOS)的周期性孕激素治疗——一位女性的 6 个月单臂经验变化初步研究》
Medicina (Kaunas). 2021 Sep 26;57(10):1024. doi: 10.3390/medicina57101024.